Report - VAV3 mediates resistance to breast cancer endocrine therapy · Santa Clara, CA, USA). RNAs were amplified using the Ribo-SPIA system (NuGEN Technologies, San Carlos, CA, USA) and

Please pass captcha verification before submit form